Health-related quality of life of children with first onset steroid-sensitive nephrotic syndrome.

"Declarations Ethics approvalThe LEARNS study was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by an institutional review board (Netherlands: Amsterdam University Medical Centers, University of Amsterdam, 2017_301; Belgium: Onze Lieve Vrouwziekenhuis Aalst, 2019/042) and competent authorities of both countries. Consent to participateWritten informed consent and/or assent (as appropriate) was obtained from the child (age ≥ 12 years) and legal representative(s). Financial disclosureAll authors have no financial relationship relevant to this article to disclose. Competing interestThe authors have no competing conflicts to disclose. Financial disclosure All authors have no financial relationship relevant to this article to disclose. Competing interest The authors have no competing conflicts to disclose."

"Funding The LEARNS study is funded by a consortium grant from the Dutch Kidney Foundation (CP16.03). Additional financial support was granted by Innovatiefonds Zorgverzekeraars and the Dr. C.J. Vaillant Fund."